Search results
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 51 minutes agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
The path to a better tuberculosis vaccine runs through Montana
Bozeman Daily Chronicle· 2 weeks agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 1 day agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 3 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 18 hours ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
CORRECTED-UPDATE 3-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters via Yahoo Finance· 3 days agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued and continues to suffer ...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
FOX 23 News Albany· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 week agoIn a Phase IIb...University and the Serum Institute of India, leveraging Novavax’s Matrix-M...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 16 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...